UGC Salud Mental, Hospital Universitario Virgen Macarena, Seville, Spain; Centro de Investigación Biomédica en Red Salud Mental (CIBERSAM), Seville, Spain; Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain.
UGC Salud Mental, Hospital San Juan de la Cruz, Úbeda, Spain.
J Psychiatr Res. 2021 May;137:486-490. doi: 10.1016/j.jpsychires.2021.03.023. Epub 2021 Mar 18.
This study examined the impact of psychotic relapse on the diagnostic stability of acute and transient psychotic disorders (ATPD), and how this potential risk factor could differentiate 'acute polymorphic psychotic disorder without symptoms of schizophrenia' (APPD; ICD-10 code F23.0) from the remaining non-APPD subtypes (F23.1-9). A two-year cohort study was performed on 68 patients with first-episode ATPD. At the end of follow-up, the diagnostic stability of ATPD was 55.9% and the overall rate of psychotic relapse was 61.8%. Statistical analysis showed that recurrence was an independent risk factor for diagnostic shift in ATPDs (relative risk [RR] = 1.67, 95% confidence interval [CI] = 1.17-2.39; p = 0.005) and that this risk differed among their subtypes insofar as its appearance significantly increased the likelihood of diagnostic change in patients with non-APPD subtypes (RR = 2.52, 95% CI = 1.56-4.07; p < 0.001), but not in those with APPD (RR = 0.95, 95% CI = 0.57-1.57; p = 0.844). Our findings confirm the negative implications of recurrence in patients with ATPD, encourage long-term intervention targeting relapse prevention in this population, and provide new empirical evidence in support of narrowing the ATPD category to APPD in the upcoming ICD-11.
这项研究考察了精神病复发对急性和短暂性精神病障碍(ATPD)诊断稳定性的影响,以及这种潜在的风险因素如何将“无精神分裂症症状的急性多形性精神病障碍”(APPD;ICD-10 编码 F23.0)与其余非 APPD 亚型(F23.1-9)区分开来。对 68 例首次发作的 ATPD 患者进行了为期两年的队列研究。在随访结束时,ATPD 的诊断稳定性为 55.9%,精神病复发的总发生率为 61.8%。统计分析表明,复发是 ATPD 诊断转变的独立危险因素(相对风险 [RR] = 1.67,95%置信区间 [CI] = 1.17-2.39;p = 0.005),而且这种风险在其亚型之间存在差异,因为它的出现显著增加了非 APPD 亚型患者诊断改变的可能性(RR = 2.52,95% CI = 1.56-4.07;p < 0.001),但在 APPD 患者中则不然(RR = 0.95,95% CI = 0.57-1.57;p = 0.844)。我们的发现证实了 ATPD 患者复发的负面影响,鼓励针对该人群复发预防的长期干预,并为即将出台的 ICD-11 将 ATPD 类别缩小为 APPD 提供了新的实证依据。